American Medical Systems Gives Notice of Make-Whole Fundamental Change Conversion Rights to Holders of 4.00% Convertible Senior Subordinated Notes Due 2041

American Medical Systems Holdings, Inc. AMMD announced that, pursuant to the terms of the indenture governing its 4.00% Convertible Senior Subordinated Notes due 2041, a “Make-Whole Fundamental Change” occurred on June 17, 2011 as a result of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 10, 2011 among Endo Pharmaceuticals Holdings Inc., NIKA Merger Sub, Inc., a wholly owned indirect subsidiary of Endo, and AMS. As previously disclosed, under the Merger Agreement, Endo acquired AMS for $30.00 per share of common stock, par value $0.01 per share of AMS. Merger Sub merged with and into AMS on June 17, 2011, with AMS continuing as the surviving corporation and a wholly owned subsidiary of Endo. Completion of the Merger constitutes a Make-Whole Fundamental Change under the 2041 Indenture.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsOfferingsHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!